You are here: HomeResearchProjects and Grants

Research Projects and Grants

Research Projects (Past and Current)



1. Safety, Immunogenicity and efficacy of Autoclaved leishmania major vaccine (ALM) in an endemic area of L. donovani infection in eastern Sudan. TDR (Professor Eltahir .A.G. Khalil & Professor Ahmed M. Elhassan)

2. Safety and immunogenicity of ALUM/ALM vaccine in Healthy Sudanese volunteers (Professor Eltahir .A.G. Khalil & Professor Ahmed M. Elhassan).

3. Immunochemotherapy for patients with persistent post kala-azar dermal leishmaniasis (PKDL) using Alum-precipitated ALM+BC vaccine and sodium stibogluconate: a hospital-based approach.( (Professor Eltahir .A.G. Khalil & Professor Ahmed M. Elhassan)

4. Immune profile and clinical presentations of patients with tuberculous lymphadenitis in the Sudan. (Professor Eltahir .A.G. Khalil )
5. Latent M.tuberculosis infection: prevalence & Risk Factors in Central & Eastern Sudan. (Professor Eltahir .A.G. Khalil )

6. Anaemia of chronic malaria: the role of depressed erythropoietin response. (Professor Eltahir .A.G. Khalil )

7. Congenital Malaria: a neonatal prospectus. (Professor Eltahir .A.G. Khalil )

8. Sickle cell anaemia: a card/registry system for the control of HbS in nomadic tribes in western Sudan. (Professor Eltahir .A.G. Khalil )

9. Sickle haemoglobin screening: Cellulose acetate versus ID technique. (Professor Eltahir .A.G. Khalil )

10. Immunochemotherapy of Post Kala-azar Dermal Leishmaniasis.

11. AID to displaced people in Sudan: magnitude and efficiency. (Professor Eltahir .A.G. Khalil )

12. LEAP 0104 project entitled “A multicentre comparative trial of efficacy and safety of Sodium Stibogluconate (SSG) versus Paromomycin (PM) versus Combination of SSG and PM as first line treatment for visceral leishmaniasis in Ethiopia, Kenya and Sudan”. July 2004 to date. (Dr. Ahmed Mudawi Musa).

13. Single High dose Ambisome for primary Sudanese visceral Leishmaniasis. (Professor Eltahir.A.G. Khalil & Dr Ahmed Mudawi Musa )

14. Miltefosine/SSG/Ambisome combination regimens for primary Sudanese visceral leishmaniasis. (Professor Eltahir .A.G. Khalil & Dr Ahmed Mudawi Musa)

15. Immunochemotherapy for patients with persistent PKDL using Alum-precipitated ALM+BCG vaccine and sodium stibogluconate: a field approach. (Professor Eltahir .A.G. Khalil & Professor Ahmed M. Elhassan )

16. LeishF2/SSG Immunochemotherapy for patients with persistent PKDL ((Professor Eltahir .A.G. Khalil )

17. Epidemiological, clinical and therapeutic studies on leishmaniasis in the Sudan. (Prof. Ahmed M. Elhassan).

18. Evaluation of molecular biological and serological methods in the diagnosis of leishmaniasis under field conditions. (Prof. Ahmed M. Elhassan).

19. Immunopathology of leishmaniasis. (Prof. Ahmed M. Elhassan).

20. Vaccines against leishmaniasis. (Prof. Ahmed M. Elhassan).

21. Epidemiology and immunopathology of mycetoma in the Sudan. (Prof. Ahmed M. Elhassan).

22. Epidemiology of leprosy in the southern part of Gedaref State, Sudan. (Prof. Ahmed M. Elhassan).

23. Epidemiology of malaria in two villages on the Rahad River, Gedarif State, Sudan. ((Prof. Ahmed M. Elhassan).

24. Cancer and infectious agents (Prof. Ahmed M. Elhassan).

25. Research grants: Grants received from TDR, EC, Wellcome Trust, DANIDA and most recently from The Academy of Sciences for the Third World (TWAS) to work on nasopharyngeal cancer ((Prof. Ahmed M. Elhassan).

26. GIS and epidemiology of Malaria in Sudan. Ongoing. (Dr. Ibrahim Elhassan).

27. Clinical and immunological characterization of Tropical spleenomegly syndrome in Sudan. Ongoing. (Dr. Ibrahim Elhassan).

28. Humoral and cellular immune responses to Malaria vaccine candidates. Ongoing. (Dr. Ibrahim Elhassan).

29. Impact of malaria-Helminthes co infection on clinical and immunological immune responses to malaria. Ongoing. (Dr. Ibrahim Elhassan).

30. African immunoassay to malaria vaccine candidates project. 2007-2009. (Co-Investigator – Dr. Ibrahim Mohamed Elhassan).

31. Epidemiological study of malaria in areas of seasonal malaria transmission in Ethiopia and Sudan. Supported by WHO/TDR/ MIM. 2004-2008. (Dr. Ibrahim Mohamed Elhassan).

32. Genetic Diversity and Susceptibility to Malaria. (Co-Investigator, member of immunology cluster) supported by EU. 2004-2007. (Dr. Ibrahim Mohamed Elhassan).

33. Natural History of PKDL and it is role in transmission. Supported by TDR/WHO 1999-2004. (Dr. Ibrahim Mohamed Elhassan).

34. The role of antigenic variation in maintenance of asymptomatic malaria infections throughout the Sudanese dry season 1998-2001. Supported by TDR/WHO. (Dr. Ibrahim Mohamed Elhassan).

35. The role of strain specific immunity in the development of strain specific immunity Supported by. Tropical Medicine Award, The Wellcome Trust Fellowship, UK 1998-2001

36. Genetic Epidemiology in Sudan (International Centre For Genetic Engineering And Biotechnology).1997-2000 (Prof. Muntaser Ibrahim)

37. 12. Kala-Zar In The Sudan, The Role of Host and Parasite Genetics In Determining Disease Outcome (The Wellcome Trust, Collaborative Research Grant (Principal Applicant) 1999-2002 (Prof. Muntaser Ibrahim).

38. Genetic Susceptibility to Visceral Leishmaniasis: Comparative Studies in India, Sudan And Brazil (Prof. Muntaser Ibrahim-Co-Applicant). 2007- Ongoing

39. Detection of Drug Resistant Malaria and Tuberculosis Supported By IAEA (RAF/6/025) Regional Project (Prof. Muntaser Ibrahim).

40. The Epidemiological Components of Cutaneous Leishmaniasis Outbreaks in Tuti Island. A Field and Simulation Approach (World Health Organization EMRO). 2002-2003. (Prof. Muntaser Ibrahim).

41. Genetic Diversity and Susceptibility to Malaria. Part of the Biomalpar Consortium Funded by the European Union. (Prof. Muntaser Ibrahim). 2004-ongoing

42. Genetic of Cancer (Colorectal, Breast, Cervical). Ongoing –(Prof. Muntaser Ibrahim)

43. Genetics of Asthma – 2008-on going –Prof. Muntaser Ibrahim. Funded by Ministry of Higher Education.

44. Y chromosome and mitochondrial genetics markers and their role in shaping the current ethno-geographical picture of Sudan. Ongoing (Prof. Ibrahim).

45. Genetics of Migraine. 2007-ongoing (Prof. Muntaser Ibrahim)

46. Epidemiological study of cutaneous leishmaniasis in Tuti Island-Khartoum looking for the prevalence of the disease in human and Sand flies)-1996-1998. (Dr. Hiba Salah-Eldin Mohamed)

47. Molecular diagnosis of Leishmaniasis -1995-1998 (Dr. Hiba Salah-Eldin Mohamed)

48. Genetic susceptibility to visceral leishmaniasis –Candidate gene approach-1998-2002. supported by the Wellcome Trust (Dr. Hiba Salah-Eldin Mohamed)

49. Functional and Genetic analysis of NRAMP1 gene using Real time PCR, reporter assay and sequencing-2007-Ongoing. Supported by The Wellcome Trust. (Dr. Hiba Salah-Eldin Mohamed)

50. Looking for possible reservoir host for visceral leishmaniasis by investigating natural infection and experimental infection in dogs -2005-2008- (Dr. Hiba Salah-Eldin Mohamed –Co-applicant).

51. Immunogenetics of cutaneous leishmaniasis in newly inhabited area in Khartoum -2007-2009. (Dr. Hiba Salah-Eldin Mohamed – Co-applicant).

52. Screening of known cytokine, nitric oxide and complement receptor one genes polymorphisms in Sudanese from malaria endemic areas. 2007-Ongoing. (Dr.Hiba Salah-Eldin Mohamed) Supported by Biomalpar and University of Khartoum.

53. Functional genomics of visceral leishmaniasis -2007-Ongoing.. Supported by Royal society-Pfizer award. (Dr. Hiba Salah-Eldin Mohamed)

54. Plasmodium falciparum var genes expression and their impact on Malaria manifestations- 2010- 2012. Supported by Ministry of Higher Education Grant. (Dr. Hiba Salah-Eldin Mohamed)

55. Genetics Susceptibility to Diabetes Type 2 – 2010. (Dr. Hiba Salah-Eldin Mohamed) Waiting for Fund.

56. Identificaiton of possible reservoir hosts of Leishmania
donovani in kala-azar endemic region in eastern Sudan. 1992-1993 World Health Grant # 920144. (PI -Professor Maowia M. Mukhtar.

57. Epidemiology of Malaria and rapid epidemiological mapping (REMO) of Onchocerca volvulus infection in Sudan.1995-1996 World Health Grant # 950011. (PI -Professor Maowia M. Mukhtar).
58. Investigation of Multiple antibiotic resistances among bacterial Pathogens. University of Khartoum Research Grant. (PI -Professor Maowia M. Mukhtar).

59. Pathogenesis of different clinical presentation of Onchodermatitis in natural and ivermectin treated Sudanese. World Health Organization Grant # 940452; 1995-1995. (Co- PI -Professor Maowia M. Mukhtar).

60. Atlas GIS grant to map Onchocerca volvulus infection in Sudan. World Health Organization. 1995-1996 (Co- PI -Professor Maowia M. Mukhtar).

61. Immunology and histamine release in Onchocerciasis patients pre and post ivermectin treatment. World Health Organization grant number 960636. (Co- PI -Professor Maowia M. Mukhtar).

62. Cellular immune response of camel peripheral blood lymphocytes to Tryapanosoma evansi, Rinderpest, Hydata and Brucella antigens Jan 1997 to June 1998. International Foundation of Science grant number B/2584-1 (PI -Professor Maowia M. Mukhtar).

63. Study of the host and parasite factors associated with Post Kala-azar Dermal Leishmaniasis (PKDL). (PI -Professor Maowia M. Mukhtar). 1998 to 1999. HO/TDR/EMRO grant numbe98/109.

64. Parasite determinants associated with Post Kala Azar dermal Leishmaniasis in Sudan. (PI -Professor Maowia M. Mukhtar). WHO/TDR grant number 990559. 1999 – 2000.

65. Molecular clustering and drug resistance of Mycobacterium TB of different regions of Sudan. (PI -Professor Maowia M. Mukhtar). WHO/ TDR grant No. A0810. 2000 to 2002.

66. Efficacy of measles mass vaccination in urban and periurban sites in Khartoum, Sudan. (PI -Professor Maowia M. Mukhtar). WHO grant No. YP/181. 2001 to 2003.

67. The burden of pulmonary tuberculosis in eastern Sudan. (Senior fellowship EDCTP (Professor Maowia M. Mukhtar). 2005.

68. Proteomics of the urine of Kala-Azar patients. (PI -Professor Maowia M. Mukhtar). ICGEB grant 2005- 2006.

69. Biomarkers of Mycobacterium TB infection. (PI -Professor Maowia M. Mukhtar). TDR/ FIND grant. 2006 – 2007.

70. Correlates of protective immunity to Leishmania infection (Co- PI Prof. Maowia M. Mukhtar) 2005 – 2006. UBS grant

71. DNA heterogeneity of Onchocerca volvulus isolates from different Onchocerciasis Endemic regions of Sudan. Supported by TDR\ WHO. (PI Prof. Maowia M. Mukhtar)

72. Immunity in Bovine Schistosomiasis. Supported by a grant from The EEC.( PI Prof. Maowia M. Mukhtar

73. Proteomics of the urine of Kala-Azar patients. Supported by CRDF-USA. (PI Prof. Maowia M. Mukhtar)

74. Biomarkers of the urine and sputum of Mycobacterium TB patients. Supported by TDR (PI Prof. Maowia M. Mukhtar)

75. Diagnosis of Visceral Leishmaniasis: a multicenter study of global network for diagnosis of Visceral Leishmaniasis. Supported by WHO/ TDR. (PI Prof. Maowia M. Mukhtar)

76. Improvement of diagnosis of pulmonary tuberculosis .Supported by EDCTP. (PI Prof. Maowia M. Mukhtar)

77. Surveys on situation analysis in refugee camps and internally displaced people, (eastern Sudan, Dar elsalam Camp (IDP from southern Sudan). (Prof. ElTahir AG Khalil)

78. Rapid assessment of leishmaniasis situation in western Sudan among nomadic tribes using GIS, TDR-funded project (2004, PI Dr. A. H. Shareif)

79. Immune profile and clinical presentations of patients with tuberculous lymphadenitis in the Sudan.

80. The mechanisms of drug unresponsiveness in patients with visceral leishmaniasis pharmacokinetics and parasite factors, LEAP0104 (DNDi sponsorship). (Dr. Ahmed Mudawi Musa).

81. Molecular diagnosis of leishmaniasis using PCR. (1999-2000). (Dr. Muzamil Mahdi Abdel Hamid)

82. Parasite Genetic factors deteriming the outcome of to visceral leishmaniasis –genetics variations using minisatellite DNA markers (1999-2002). MSc research. (Dr. Muzamil Mahdi Abdel Hamid)

83. Exploratory research to improve the technology of transfection of malaria parasite using Plasmodium knowlesi parasite model, PhD research 2004-2005. (Dr. Muzamil Mahdi Abdel Hamid).

84. Identification of new malaria vaccine candidates emerging from proteomic and genomic analysis, PhD research, 2006-2007. (Dr. Muzamil Mahdi Abdel Hamid).

85. Assessment of vaccine characteristics of Apical Membrane Antigen 1 (AMA) using animal models, PhD research, 2007-2009. (Dr. Muzamil Mahdi Abdel Hamid).

86. African immunoassay (AIA). AMANET network for evaluation of malaria candidates. 2007-2009. (Dr. Sahar Mubarak Bakhiet co-investigator).

87. Monitoring of anti Leishmania antibody responses for early diagnosis and prognosis of visceral Leishmaniasis. 2008-2009. Supported by Ministry of Higher Education. (Dr. Sahar Mubarak Bakhiet).

88. Molecular characterization and taxonomy of Sudanese Leishmania parasite using different molecular and genetic markers. Ongoing. (Dr. Sahar Mubarak Bakhiet).

89. Immune response to Leishmania parasite in different clinical forms of Leishmaniasis. Ongoing (Dr. Sahar Mubarak Bakhiet).

90. Biomarkers of Tuberculosis and its application in the diagnosis of the disease. Ongoing (Dr. Sahar Mubarak Bakhiet).

91. Monitoring of anti Leishmania antibody responses for early diagnosis and prognosis of Visceral Leishmaniasis (Dr.Sahar M Bakhiet)

92. Oral pathology Professor Ahmed M. Elhassan and Dr Imad EL Emairi. ongoing .


93. Evaluation of Rapid diagnostic test for Visceral Leishmaniasis . sponsored by Infectious Disease Research Institute (IDRI) 2009-2011.
Grants Awarded to Academic Staff

94. WHO/TDR grant. The genetic diversity of Leishmania parasites from Sudan based on DNA and protein polymorphism. 1995-1997. (Prof. Muntaser Eltyeb Ibrahim).

95. Wellcome Visiting Research Fellow, University of Cambridge, 1997-1998 Department of Pathology, studying the Genetics of the parasite Leishmania donovani. (Prof. Muntaser Eltyeb Ibrahim).

96. WHO grant. Leishmanin skin testing serology and the polymerase chain reaction in the establishment of man as possible reservoir for Leishmania infection (1997-1998. (Prof. Muntaser Eltyeb Ibrahim).

97. Third World Academy of Science grant. Characterization of a possible signal transduction pathway for the action of the anttileishmanial drug Pentostam (Prof. Muntaser Eltyeb Ibrahim).

98. International Centre for Genetic Engineering and Biotechnology grant. Genetic epidemiology in Sudan.1997-2000. (Prof. Muntaser Eltyeb Ibrahim).

99. The Wellcome Trust, Collaborative Research Grant. Kala-zar in the Sudan, The role of Host and parasite genetics in determining Disease outcome. 1999-2002. (Prof. Muntaser Eltyeb Ibrahim).

100. The Wellcome Trust grant. Genetic Susceptibility to Visceral Leishmaniasis: Comparative studies in India, Sudan and Brazil (Co-investigator. Prof. Muntaser Eltyeb Ibrahim)

101. IAEA (RAF/6/025) regional project. Detection of drug resistant malaria and tuberculosis. (Prof Muntaser Eltyeb Ibrahim).

102. WHO/EMRO. The epidemiological components of cutaneous leishmaniasis outbreaks in Tuti Island, a field and simulation approach. 2002-2003. (Prof Muntaser Eltyeb Ibrahim, Prof. Ahmed E. Elhassan).

103. Part of the BioMalPar consortium funded by the European Union. Genetic diversity and susceptibility to malaria. 2004-ongoing.. (Prof Muntaser Eltyeb Ibrahim, Dr. Ibrahim Elhassan).

104. TDR/WHO Project ID 950628. Autoclaved Leishmania Major Vaccine in Prevention of Kala-Azar in Sudan. (Prof. EAG Khalil., Prof. Ahmed M. ElHassan).

105. TDR/WHO Project ID 980971. ALUM/Autoclaved Leishmania Major Vaccine In Healthy Sudanese Volunteers In Khartoum. (Prof. EAG Khalil, Prof. Ahmed M.ELhassan).

106. TDR/WHO ID A30468. Safety, Immunogenicity & Possible Potential Curative Effect of ALUM/ALM+BCG Vaccine Plus SSG in the Patients With Persistent Post Kala-Azar Dermal Leishmaniasis. (PI. Professor EAG Khalil, Prof. Ahmed M. Elhassan).

107. DNDi-LEAP 0104 Project: A Multicentre Randomized Controlled Clinical trial of A Combination of Sodium Stibogluconte (SSG) Plus Paromomycin (PM) as A First Line Treatment of Visceral Leishmaniasis Vs SSG Alone Vs PM Alone In Ethiopia, Kenya And Sudan. (Ahmed Mudawi Musa, Prof. EAG Khalil, Prof. Ahmed M. Elhassan).

108. WHO/TDR grant. Efficacy of Alum/Alm+Bcg Combined With Sodium Stibogluconate (Ssg) Compared With Ssg Alone In The Treatment Of Post Kala Azar Dermal Leishmaniasis. (PI. Professor EAG Khalil, Prof. Ahmed M. Elhassan).

109. IDRI/Seatle, USA; WHO/TDR grant. A Phase 1, Randomized, Double-Blind, Adjuvant- and Placebo-Controlled Study to Evaluate The Safety, Tolerability, and Immunogenicity of the Leish-F2 + Mpl-Se Vaccine (Recombinant Three-Antigen Leishmania Polyprotein Leish-F2 With Adjuvant Mpl-Se) in Combination With Sodium Stibogluconate In The Treatment of Patients With Post Kala-Azar Dermal Leishmaniasis. (PI. Professor EAG. Khalil, Prof. Ahmed M. Elhassan, Dr. Ahmed M. Musa).

110. Local sponsorship. The mechanisms of drug unresponsiveness in patients with visceral leishmaniasis. (Prof. E AG Khalil).

111. Local sponsorship Tuberculous lymphadenitis, clinical, cytologica, microbiological and drug response aspects: towards developing a clinical algorithm to improve patients’ management. (Prof. EAG Khalil).

112. IEND funding. Anaemia of Visceral leishmaniasis: Possible role of blunt erythropoietin response. (Prof EAG Khalil).

113. IEND funding Malaria morbidity and mortality in an area of stable transmission in eastern Sudan: possible role of Hb AS, Hb F levels and G-6-P-D deficiency. (Prof EAG Khalil).

114. IEND funding. The febrile child: towards developing a clinical algorithm to improve patients’ management. Collaborative study with the Central Police Hospital (Prof. EAG Khalil/Dr. Fawzi A. Mahgoub).

115. P.faciparum infections and anti-malaria drug resistance: a national-wide approach with GIS ((IEND; Prof.EAG Khalil/M.O. Elhassan).

116. WHO ID 920144 grant. To identify possible reservoir hosts of Leishmania donovani in kala-azar endemic region in eastern Sudan. 1992-1993. (Prof. Maowia Mohamed Mukhtar).

117. WHO grant ID 950011. To study the Epidemiology of Malaria and to rapid epidemiological mapping (REMO of Onchocerca volvulus infection in Sudan. 1995-1996 (Prof. Maowia Mohamed Mukhtar).

118. University of Khartoum Research Grant. Investigation of Multiple antibiotic resistances among bacterial Pathogens. (Prof. Maowia Mohamed Mukhtar).

119. WHO grant ID 940452. To study the pathogenesis of deferent clinical presentation of Onchodermatitis in natural and ivermectin treated Sudanese . 1995-1995. (Co-Investigator- Prof. Maowia Mohamed Mukhtar).

120. WHO grant. Atlas GIS grant to map Onchocerca volvulus infection in Sudan. 1995-1996. (Prof. Maowia Mohamed Mukhtar).

121. WHO grant ID 960636. To study the immunology and histamine release in Onchocerciasis patients pre and post ivermectin treatment. (Prof. Maowia Mohamed Mukhtar).

122. International Foundation of Science grant ID B/2584- 1. To study the cellular immune response of camel peripheral blood Lymphocytes to Tryapanosoma evansi , Rinderpest , Hydata and Brucella antigens Jan 1997 to June 1998. (Prof. Maowia Mohamed Mukhtar).

123. WHO/TDR/EMRO grant ID 98/109. To study the host and parasite factors associated with Post Kala-azar Dermal Leishmaniasis (PKDL). 1998 to 1999. (Prof. Maowia Mohamed Mukhtar).

124. WHO/TDR grant ID 990559. To study the parasite determinants associated with Post Kala Azar dermal Leishmaniasis in Sudan. 1999 – 2000. (Prof. Maowia Mohamed Mukhtar).

125. WHO TDR grant ID A0810. Molecular clustering and drug resistance of Mycobacterium TB of different regions of Sudan. 2000 to 2002. (Maowia Mohamed Mukhtar).

126. WHO grant ID YP/181. Efficacy of measles mass vaccination in urban and periurban sites in Khartoum, Sudan 2001 to 2003. (Prof. Maowia Mohamed Mukhtar).

127. Senior fellowship EDCTP. To study the burden of pulmonary tuberculosis in eastern Sudan 2005.. (PI- Prof. Maowia Mohamed Mukhtar).

128. ICGEB grant. Proteomics of the urine of Kala-Azar patients 2005- 2006. (Prof. Maowia Mohamed Mukhtar).

129. TDR/ FIND grant. Biomarkers of Mycobacterium TB infection 2006 – 2007 (Prof. Maowia Mohamed Mukhtar).

130. UBS grant. Correlates of protective immunity to Leishmania infection 2005 – 2006.. (Co-investigator. Prof. Maowia Mohamed Mukhtar).

131. WHO/ TDR/ FIND. Biomarkers of pulmonary tuberculosis Sudanese patients. 2006 – 2008. (Prof. Maowia Mohamed Mukhtar).

132. WHO/ TDR grant . Diagnosis network of Visceral Leishmaniasis. Ongoing. (Prof. Maowia Mohamed Mukhtar).

133. WHO/ TDR training fellowship for 8 months- Cambridge University- UK (1999). (Dr. Hiba Salah-Eldin Mohamed).

134. The Wellcome Trust, Collaborative Research Grant. Kala-zar in the Sudan, The role of Host and parasite genetics in determining Disease outcome. 1999-2002 (Research assistant. Dr. Hiba Salah-Eldin Mohamed)

135. Wellcome Trust Research Development Award (2004-2007). Genetics and Functional analysis of SLC11A1 (formerly NRAMP1) polymorphisms in susceptibility to visceral leishmaniasis in the Sudan. In collaboration with Prof. Blackwell University of Cambridge. UK. (Co-Investigator- Dr. Hiba Salah-Eldin Mohamed)

136. University of Khartoum Research fund for one years (2007) (Genetics and immunological factors determining the severity of P. falciparum infection. (Dr. Hiba Salah-Eldin Mohamed)

137. WHO capacity strengthening program grant for faculty of Science (2005). “Investigation of possible reservoir host in Eastern Sudan (Co-investigator. Dr. Hiba Salah-Eldin Mohamed)

138. Royal Society Pfizer Award (2007). Recognition of my work on the genetic basis of susceptibility to visceral leishmaniasis in the Sudan. the research entitled “Functional Genomic of Visceral leishmaniasis and PKDL in the Sudan”. (Dr. Hiba Salah-Eldin Mohamed).

139. Ministry of Higher Education Research Grant. Plasmodium falciparum Var gene expression and genetic diversity and their impact on malaria manifestation. 2010-2012. (Dr. Hiba Salah-Eldin Mohamed, Prof. Muntaser E. Ibrahim).

140. PhD Followship from the European malaria vaccine intiative (EMVI) and Biomedical Primate Centre (BPRC), Rijswijk, The Netherlands. 2004-2008. (Dr. Muzamil Mahdi Abdel Hamid).

141. MSc fellowship DAAD, Germany and University of Khartoum,Sudan. 2000-2002. (Dr. Muzamil Mahdi Abdel Hamid).

142. DAAD scholarship programs for Master and PhD Scholarships 2002-2006. (Dr. Sahar Mubarak Bakhiet).

143. Training grant .WHO/TDR 2005. (Dr. Sahar Mubarak Bakhiet).

144. Ministry of Higher Education Research grant. 2008. (Dr. Sahar Mubarak Bakhiet).

145. LEAP 0104 grant. A multicentre comparative trial of efficacy and safety of Sodium Stibogluconate (SSG) versus Paromomycin (PM) versus Combination of SSG and PM as first line treatment for visceral leishmaniasis in Ethiopia, Kenya and Sudan”. July 2004 to date. (PI- Dr. Ahmed Mudawi Musa, Prof. EK Khalil, Prof. Ahmed M. Elhassan).

146. AMANET grant. African immunoassay to malaria vaccine candidates project. 2007-2009. (Prof. Moawia M. Mukhtar, Dr. Ibrahim Mohamed Elhassan, Dr. Sahar M. Bakhiet).

147. WHO/TDR /MIM. Epidemiological study of malaria in areas of seasonal malaria transmission in Ethiopia and Sudan. 2004-2008. (Dr. Ibrahim Mohamed Elhassan).

148. Ministry of Higher Education Research Grant 2004-2005. (Dr. Ibrahim Mohamed Elhassan).

149. TDR/WHO grant. Natural History of PKDL and it is role in transmission. 1999-2004. (Dr. Ibrahim Mohamed Elhassan).

150. TDR/WHO grant. The role of antigenic variation in maintenance of asymptomatic malaria infections throughout the Sudanese dry season 1998-2001. (Dr. Ibrahim Mohamed Elhassan).

151. Tropical Medicine Award and the Wellcome Trust Fellowship, UK. The role of strain specific immunity in the development of strain specific immunity. 1998-2001. (Dr. Ibrahim Mohamed Elhassan).

152. Ph.D. DANIDA Fellowship, Denmark. 1991-1995. (Dr. Ibrahim Mohamed Elhassan).